When assessing the association between ADIPOQ polymorphisms and CKD and the interaction of ADIPOQ polymorphisms and metal levels on CKD, further studies with larger sample sizes are required to improve the precision of point estimates. This evidence concerns the gene ADIPOQ and chronic kidney disease.